Kanda S Ramasamy

Summary

Affiliation: Valeant Pharmaceuticals International
Country: USA

Publications

  1. ncbi request reprint Solid-phase parallel synthesis of 4-beta-D-ribofuranosylpyrazolo[4,3-d]pyrimidine nucleosides
    Kanda S Ramasamy
    R and D Division, Valeant Pharmaceuticals, Costa Mesa, California 92626, USA
    Nucleosides Nucleotides Nucleic Acids 24:1947-70. 2005
  2. ncbi request reprint Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents
    Chamakura V N S Varaprasad
    Drug Discovery, Valeant Pharmaceuticals Research and Development, 3300 Hyland Avenue, Costa Mesa, CA 92626, USA
    Bioorg Chem 35:25-34. 2007

Collaborators

  • Haoyun An
  • Chamakura V N S Varaprasad
  • Esmir Gunic
  • Zhi Hong
  • Weidong Zhong
  • Vicky Lai
  • Jean Luc Girardet

Detail Information

Publications2

  1. ncbi request reprint Solid-phase parallel synthesis of 4-beta-D-ribofuranosylpyrazolo[4,3-d]pyrimidine nucleosides
    Kanda S Ramasamy
    R and D Division, Valeant Pharmaceuticals, Costa Mesa, California 92626, USA
    Nucleosides Nucleotides Nucleic Acids 24:1947-70. 2005
    ..Cleavage of the products from the solid support with 30% HFIP in a parallel fashion yielded nucleoside libraries simultaneously, and they were analyzed and characterized by high-throughput LC-MS...
  2. ncbi request reprint Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents
    Chamakura V N S Varaprasad
    Drug Discovery, Valeant Pharmaceuticals Research and Development, 3300 Hyland Avenue, Costa Mesa, CA 92626, USA
    Bioorg Chem 35:25-34. 2007
    ..Among the compounds examined 4-methylthio (18) and 5-carboxamide oxime derivatives (23 and 27) of Toyocamycin were found to have good activity and selectivity...